Medpace Holdings, Inc. (MEDP)

↓ Download CSV

CIK 0001668397 · Nasdaq · Services-Commercial Physical & Biological Research

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Medpace Holdings, Inc. reported revenue of $2.53B, up 20.0% from the prior year. The company was profitable, with a net margin of 17.8%. It held $1.98B in total assets against $1.52B in total liabilities.

Key ratios (FY2025)

21.1%
Operating margin
17.8%
Net margin
98.3%
Return on equity
+20.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$2.53B$2.11B$1.89B$1.46B$1.14B$925.92M$860.97M$704.59M$436.15M$421.58M
Operating Income$534.93M$446.87M$336.82M$278.70M$198.62M$167.04M$127.26M$101.05M$64.86M$52.49M
Net Income$451.12M$404.39M$282.81M$245.37M$181.85M$145.38M$100.44M$73.19M$39.12M$13.43M
EPS (Diluted)$15.28$12.63$8.88$7.28$4.81$3.84$2.67$1.97$0.98$0.37
Total Assets$1.98B$2.10B$1.66B$1.35B$1.66B$1.39B$1.14B$967.93M$950.72M$979.11M
Total Liabilities$1.52B$1.28B$1.10B$966.11M$707.01M$584.90M$416.79M$378.23M$447.19M$368.39M
Shareholders' Equity$459.07M$825.54M$558.95M$386.39M$952.93M$805.78M$726.28M$598.86M$509.26M$610.71M
Cash & Equivalents$497.05M$669.44M$245.45M$28.27M$461.30M$277.77M$131.92M$23.27M$26.48M$37.10M
Operating Cash Flow$713.22M$608.82M$433.37M$388.05M$263.33M$258.68M$201.87M$156.58M$97.39M$91.73M
Capital Expenditures$31.36M$36.55M$36.65M$36.88M$28.27M$31.34M$17.91M$16.02M$11.72M$13.54M
Shares Outstanding28.37M30.63M30.75M31.09M36.01M35.52M36.07M35.67M35.47M40.66M